The probiotic bacteria engineered to treat diabetes

TL;DR - Genetically engineered probiotic bacteria lowered high blood sugar in animal trials, suggesting a potential microbial therapy for diabetes. The brief provided does not specify the bacterial strain, engineering method, or trial results.

• The treatment uses modified probiotic bacteria.
• Evidence is currently limited to animal studies.
• The reported outcome was reduced high blood sugar.
• Human safety and effectiveness are not established in the provided content.